University of Oklahoma
For more information, see ClinicalTrials.gov NCT04928508
The purpose of this research is to test the safety of the study drug (SHetA2) and see what effects (good and bad) this drug has on patients with recurrent cervical, ovarian, or endometrial cancer.
Ovarian Cancer, Endometrial Cancer, Cervix Cancer
Kathleen Moore, MD, Ingrid Block, Lead Gynecology Oncology Nurse